Contributions
2,802 recent contributions in Hansard
HANSARDScience, Innovation and TechnologyIt is not entirely dependent on our AstraZeneca programme, and indeed, as I have already pointed out, the piece of work in which it was intending to invest—I hope I will get the…12 Feb 2025HANSARDDesignated Vendor Directions: EnforcementToday the Department for Science, Innovation and Technology has published guidelines on how the Secretary of State will approach compliance and enforcement of designated vendor…11 Feb 2025HANSARDAstraZenecaIt is not entirely dependent on our AstraZeneca programme, and indeed, as I have already pointed out, the piece of work in which it was intending to invest—I hope I will get the…03 Feb 2025HANSARDAstraZenecaFirst, let me clear up a point about national insurance contributions. I know that the Conservative party likes to bang on about them, but many people do not know that 50% of…03 Feb 2025HANSARDAstraZenecaAs the largest company listed on the London Stock Exchange, employing more than 10,000 people and investing about £2.5 billion every year in the UK, AstraZeneca is a close and…03 Feb 2025HANSARDAstraZenecaIt is almost sad, sometimes. I just wish the hon. Member had been here for the last 14 years. I wish he had been here when we had endless strikes in every single part of every…03 Feb 2025HANSARDAstraZenecaThe right hon. Lady puts it in a particular way, but it is not a way that is consonant with the facts. The fact is that this deal had not been signed or got over the line by the…03 Feb 2025HANSARDAstraZenecaNot necessarily for this specific deal, but certainly for a deal with AstraZeneca, yes.03 Feb 2025HANSARDAstraZenecaNo.03 Feb 2025HANSARDAstraZenecaThere are all sorts of bids coming in now, none of which I am in charge of, but we have seen significant added investments in the UK since the autumn. For instance, Iberdrola is…03 Feb 2025HANSARDAstraZenecaMy hon. Friend is right: not only do we need to enable smaller companies to start up, but we need to enable them to grow to scale. Otherwise, the danger is that we develop the…03 Feb 2025HANSARDAstraZenecaI will take support from wherever I can get it, so I am grateful to the right hon. Gentleman. It is a very simple point that when the Government invest in businesses of whatever…03 Feb 2025HANSARDAstraZenecaI could read out the long list of investments made in the last few months, except I do not think that Mr Speaker would let me. I do not think we have time, and you would get bored…03 Feb 2025HANSARDAstraZenecaI think the hon. Gentleman needs to speak to the hon. Member who spoke earlier—oh, he’s left. I actually believe that the vaccines saved lives; I do not believe that they lost…03 Feb 2025HANSARDAstraZenecaSome of what I have already pointed out is really important. We have already said that we will have the lowest corporation tax rate in the G7, at 25%, and we are sticking with…03 Feb 2025HANSARDAstraZenecaIt does not send any kind of message like that. The point is that in the UK we have secured dramatic amounts of additional investment since the general election. What is…03 Feb 2025HANSARDAstraZenecaTo be honest, that sounded like a bid to send AstraZeneca to the United States of America. I do not think that is what hon. Members of this House should be doing; I think they…03 Feb 2025HANSARDAstraZenecaThat is precisely the job that Lord Vallance is engaged in. We are trying to make sure that our research and development budget across the whole of the UK is spent in a way that…03 Feb 2025HANSARDAstraZenecaAs I have already said, we had £63 billion of investment at the summit before Christmas, and we have had £14 billion of investment since Christmas. I have a specific…03 Feb 2025HANSARDAstraZenecaYes, and I agree with everything my hon. Friend says. The Oxford-Cambridge corridor is really important. Reading the newspapers over the weekend, I was intrigued by how many…03 Feb 2025